PPT-The Opioid Epidemic and the Role of Naloxone

Katherine Wang PharmD The Center for Children and Women Greenspoint Conflict of Interest Disclosure The presenters planners reviewers including CME administrator of todays CME activity do not have any financial relationships or commercial interests to disclose. John J. Faragon, Pharmacist, HIV Medicine. Regional Pharmacy Director, . NY/NJ AIDS Education and Training Center. Objectives. Describe the correlation between prescription drug abuse and the rate of opioid related overdose deaths. . Training of Trainers. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Agenda. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Understanding Opioids. for Peace Officers and EMTs . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . Medical Director. Kent County Health . Department. December 2, 2016. Goals. Review terminology. Discuss Kent County fatal overdose data. Review benefits and precautions with naloxone. Identify unique and dangerous characteristics of carfentanil. Intranasal Administration of Naloxone for Suspected Opiate Overdose. Objectives. Overview of the problem . HB 965. What is an Opiate. Abuse. Side effects. Overdose indicators. What is Naloxone (. Narcan. Aaron Kochar, J.D.. akochar@yahoo.com. Talk Takeaways. Indiana’s legal framework has been revised to promote widespread distribution of naloxone to all Hoosiers. Indiana Laws written to remove barriers. Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . accidental death in America . Mark . Peffer. Butler County Sheriff’s Office. Butler County . Naloxone. Manager. David’s Law-. Opioid. Overdose Reversal Act 139. Allows 1. st. Responders to possess and administer . Naloxone. Adapted from: . Community . Access . Naloxone Is . there a downside. ?. . Michael . W. Dailey, MD . Albancy. Medical Center. Motor vehicle traffic, poisoning, drug poisoning, and unintentional drug poisoning death rates: United States, 1999--2010.  . Michael Lynch, MD. Assistant Professor of Emergency Medicine and Toxicology, University of Pittsburgh. Medical Director, Pittsburgh Poison Center. . 2017 US Overdose Deaths: >72,000. 1. Rapidly rising death rate due to potency, fentanyl analogues. Medication Assisted Treatment (MAT) & Overdose Prevention. Michael Baca-Atlas, MD. Addiction Medicine . Fellow. UNC . School of . Medicine. June 14, 2019. Disclosures. The presenter has nothing to . Community Placement of Lifesaving Equipment. Naloxone. Overdose antidote. Administered via injection or nasal aerosol. Onset of action 3-15 . mins. Duration of action: 30-45 . mins. Image courtesy of Prescribe to Prevent. NALOXONE (. Narcan. ®). Developed in the 1960s. Increased opioid use and abuse. Greater . variety of available opioids . Increased demand for naloxone. Opioid . competitive antagonist. Emergent overdose treatment in hospital and . Trainer Name. location AND DATE. Learning objectives. By the end of the presentation, participants will:. Understand requirements of the Community-Based Naloxone Access Program Standing Order. Know what naloxone is and how to store, track and administer it.